Overexpression of NEAT1 has been linked to adverse features in NSCLC, such as higher TNM stage, larger tumor size, lymph node metastasis, and poorer prognosis (Zhang et al., 2017[92]). This evidence concerns the gene NEAT1 and non-small cell lung carcinoma.